Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor

PurposeThe prognosis of relapsed or refractory pediatric Wilms tumor (WT) is dismal, and new salvage therapies are needed. This study aimed to evaluate the efficacy of the combination of irinotecan and a doxorubicin hydrochloride liposome regimen for relapsed or refractory pediatric WT.Patients and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Juan Wang, Lian Zhang, Lanying Guo, Yi Que, Yu Zhang, Feifei Sun, Jia Zhu, Suying Lu, Junting Huang, Liuhong Wu, Ruiqing Cai, Zijun Zhen, Sihui Zeng, Yizhuo Zhang, Xiaofei Sun
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-09-01
coleção:	Frontiers in Oncology
Assuntos:	Wilms tumor pediatric tumor salvage regimen irinotecan doxorubicin hydrocloride liposome
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2021.721564/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!